Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Candesartan - The next anti-amyloid drug?
Sevil Yasar
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Candesartan - The next anti-amyloid drug?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Candesartan
100%
Anti-amyloidogenic
100%
Hypertensive Adults
50%
Prodromal Alzheimer's Disease
50%
Scientific Commentary
50%
Pharmacology, Toxicology and Pharmaceutical Science
Amyloid
100%
Candesartan
100%
Alzheimer's Disease
50%
Biological Marker
50%